Michael P. Barrett

19.4k citations

306 papers · 14.1k indexed · 3 hit papers · h-index 65

Impact in

Parasitology top 0.2%
- Parasites and Host Interactions
Public Health, Environmental and Occupational Health top 0.05%
- Research on Leishmaniasis Studies
- Malaria Research and Control

Papers in

Epidemiology 175
- Trypanosoma species research and implications 170
Public Health, Environmental and Occupational Health 122
- Research on Leishmaniasis Studies 105

Co-authors: Richard Burchmore Darren J. Creek Rainer Breitling Harry P. de Koning Karl Burgess Mhairi Stewart Ian H. Gilbert Frédéric Bringaud
Journals: PLoS neglected tropical diseases (18 papers)Molecular and Biochemical Parasitology (16 papers)PLoS Pathogens (14 papers)Antimicrobial Agents and Chemotherapy (14 papers)Parasitology (9 papers)
Partner nations: United Kingdom United States Switzerland

In The Last Decade

Michael P. Barrett

304 papers receiving 13.9k citations

Hit Papers

align trajectories log scale

Drug resistance and treatment failure in leishmaniasis: A 21st century challenge 2017 · 608 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2017 PLoS neglected tropical diseases
2016 Parasitology
2003 The Lancet

Peers

Countries citing papers authored by Michael P. Barrett

Since Specialization

Citations

This map shows the geographic impact of Michael P. Barrett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael P. Barrett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael P. Barrett more than expected).

Fields of papers citing papers by Michael P. Barrett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael P. Barrett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael P. Barrett. The network helps show where Michael P. Barrett may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael P. Barrett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael P. Barrett Line = papers co-authored together Michael P. Barrett links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Digital innovation, platforms, and global strategy Information and Organization ·Danielle Logue, Peter J. Williamson, Anna Roberts, Yadong Luo, Michael P. Barrett	2025	1
2	The International Education Index: A global approach to education policy analysis, performance and sustainable development British Educational Research Journal ·Serena Clark, 张慧飞, Neasa Boyle, Michael P. Barrett, Bruna R. P. Conrado, Dellys M. Soler‐Rodriguez, Ikenna D. Ebuenyi, Kevin Marshall, Katriona O’Sullivan	2022	6
3	Diminazene resistance in Trypanosoma congolense is not caused by reduced transport capacity but associated with reduced mitochondrial membrane potential Molecular Microbiology ·LUIS CARLOS DE ARAUJO SIMOES, Jane C. Munday, Godwin U. Ebiloma, Pieter C. Steketee, S. Jayaraman, Gustavo D. Campagnaro, Marzuq A. Ungogo, S. Wills, Sndor Szabados, T.G. Rowan, M. Burger, Liam J. Morrison, Michael P. Barrett, Harry P. de Koning	2021	20
4	Truncated S-MGBs: towards a parasite-specific and low aggregation chemotype RSC Medicinal Chemistry ·Johannes Kopton, Shen Fang-e, Federica Giordani, 照敏平井, Abedawn I. Khalaf, Numburu Srilanari, Kirsten Gillingwater, 李正青, Katharine C. Carter, Michael P. Barrett, Colin J. Suckling, Fraser J. Scott	2021	4
5	Transcriptional differentiation of Trypanosoma brucei during in vitro acquisition of resistance to acoziborole PLoS neglected tropical diseases ·Pieter C. Steketee, Federica Giordani, Isabel M. Vincent, Kathryn Crouch, Fiona Achcar, Nicholas J. Dickens, Liam J. Morrison, Annette MacLeod, Michael P. Barrett	2021	5
6	Experimentally Engineered Mutations in a Ubiquitin Hydrolase, UBP-1, Modulate In Vivo Susceptibility to Artemisinin and Chloroquine in Plasmodium berghei Antimicrobial Agents and Chemotherapy ·T Brieske, Katie R. Hughes, A. Roberts, V.N. Korzun, Michael P. Barrett, Andrew P. Waters	2020	24
7	Disposable Paper-on-CMOS Platform for Real-Time Simultaneous Detection of Metabolites IEEE Transactions on Biomedical Engineering ·Chunxiao Hu, Valerio F. Annese, Byoung Lae Park, Mohammed A. Al-Rawhani, XU Long-wei, James Grant, Michael P. Barrett, David R. S. Cumming	2020	13
8	New Drugs for Human African Trypanosomiasis: A Twenty First Century Success Story Tropical Medicine and Infectious Disease ·Contribution by Peter Draper and Trevor Hancock, Federica Giordani, Matthew K. Gould, Pascal Mäser, C. Burri, Jeremy C. Mottram, Srinivasa P. S. Rao, Michael P. Barrett	2020	88
9	Veterinary trypanocidal benzoxaboroles are peptidase-activated prodrugs PLoS Pathogens ·Federica Giordani, Daniel Paape, Isabel M. Vincent, Andrew W. Pountain, Piro Meleby, Eva Rico, Ning Zhang, Liam J. Morrison, Yvonne R. Freund, Michael J. Witty, Столяров Е.В., Darren Edwards, Jonathan Wilkes, Justin J. J. van der Hooft, Clément Regnault, Kevin D. Read, David Horn, Mark C. Field, Michael P. Barrett	2020	22
10	New drug, new problem: do hip fracture patients taking NOACs experience delayed surgery, longer hospital stay, or poorer outcomes? Hip International ·S. Correa, Michael P. Barrett, Wasim Khan, Mardiyah Lubita, Stephen McDonnell	2019	18
11	Protozoan persister-like cells and drug treatment failure Nature Reviews Microbiology ·Michael P. Barrett, Dennis E. Kyle, L. David Sibley, Joshua B. Radke, Rick L. Tarleton	2019	98
12	Metabolic Clustering Analysis as a Strategy for Compound Selection in the Drug Discovery Pipeline for Leishmaniasis ACS Chemical Biology ·Emily G. Armitage, Joanna Godzień, Imanol Peña, Ángeles López‐Gonzálvez, Santiago Angulo, Ana Gradillas, Vanesa Alonso‐Herranz, Julio Martín, José M. Fiandor, Michael P. Barrett, Burak Yaprak, Coral Barbas	2018	13
13	Complex Interplay between Sphingolipid and Sterol Metabolism Revealed by Perturbations to the Leishmania Metabolome Caused by Miltefosine Antimicrobial Agents and Chemotherapy ·Emily G. Armitage, Breitwieser, Joanna Godzień, Imanol Peña, Alison Mbekeani, Vanesa Alonso‐Herranz, Ángeles López‐Gonzálvez, Julio Martín, Burak Yaprak, Paul W. Denny, Michael P. Barrett, Coral Barbas	2018	36
14	The trypanocidal benzoxaborole AN7973 inhibits trypanosome mRNA processing PLoS Pathogens ·A. Linas, Isabel M. Vincent, Federica Giordani, Ina Pöhner, Michael J. Witty, T.G. Rowan, Zakaria Bengaly, Kirsten Gillingwater, Yvonne R. Freund, Rebecca C. Wade, Michael P. Barrett, Christine Clayton	2018	52
15	An evaluation of Minor Groove Binders as anti-fungal and anti-mycobacterial therapeutics European Journal of Medicinal Chemistry ·Fraser J. Scott, Byung-Sun Park, Abedawn I. Khalaf, Federica Giordani, Kirsten Gillingwater, Soumya Ramu, Alysha G. Elliott, Johannes Zuegg, ByoungJo Kim, 公三渡辺, 尹泰勳, Santosh Kumar, Mumin Ozturk, Frank Brombacher, Michael P. Barrett, Reto Guler, Colin J. Suckling	2017	19
16	Inside Doctor Livingstone: a Scottish icon's encounter with tropical disease Parasitology ·Michael P. Barrett, Federica Giordani	2016	0
17	The threonine degradation pathway of the T rypanosoma brucei procyclic form: the main carbon source for lipid biosynthesis is under metabolic control Molecular Microbiology ·Yoann Millerioux, Charles Ebikeme, Marc Biran, Pauline Morand, 正一高木, Isabel M. Vincent, Muriel Mazet, Loïc Rivière, Jean‐Michel Franconi, Richard Burchmore, Patrick Moreau, Michael P. Barrett, Frédéric Bringaud	2013	54
18	Metabolomics Guides Rational Development of a Simplified Cell Culture Medium for Drug Screening against Trypanosoma brucei Antimicrobial Agents and Chemotherapy ·Darren J. Creek, Brunda Nijagal, Dong‐Hyun Kim, Federico Rojas, Keith R. Matthews, Michael P. Barrett	2013	70
19	Explicit consideration of topological and parameter uncertainty gives new insights into a well‐established model of glycolysis FEBS Journal ·Fiona Achcar, Michael P. Barrett, Rainer Breitling	2013	13
20	Genetic characterization of glucose transporter function in Leishmania mexicana Proceedings of the National Academy of Sciences ·Richard Burchmore, Dayana Rodriguez‐Contreras, Michael Stephen Dover, Michael P. Barrett, Govind B. Modi, David L. Sacks, Scott M. Landfear	2003	112

About Michael P. Barrett

Michael P. Barrett is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health, Parasitology, Physiology and Molecular Biology, having authored 306 papers that have together received 14.1k indexed citations. Recurring topics across this work include Trypanosoma species research and implications (170 papers), Research on Leishmaniasis Studies (105 papers), Biochemical and Molecular Research (67 papers), Synthesis and Biological Evaluation (40 papers), Metabolomics and Mass Spectrometry Studies (33 papers), Parasites and Host Interactions (19 papers), HIV/AIDS drug development and treatment (19 papers) and Lysosomal Storage Disorders Research (16 papers). The work is most often cited by research in Parasitology (1.4k citations), Public Health, Environmental and Occupational Health (6.0k citations), Epidemiology (7.0k citations), Physiology (512 citations) and Organic Chemistry (2.4k citations). Michael P. Barrett has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Richard Burchmore, Darren J. Creek, Rainer Breitling, Harry P. de Koning, Karl Burgess, Mhairi Stewart, Ian H. Gilbert, Frédéric Bringaud, Andris Jankevics and Reto Brun. Their work appears in journals such as PLoS neglected tropical diseases, Molecular and Biochemical Parasitology, PLoS Pathogens, Antimicrobial Agents and Chemotherapy and Parasitology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact